Compound Detail
CHEMBL279869
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL279869 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | LFOLEZGATPHHQS-HZPDHXFCSA-N |
2
Targets
2
Activities
2
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
279.3
MW (Da)
2.16
ALogP
2
HBA
1
HBD
46.2
PSA (Ų)
0.87
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 6.52
Ki 1 meas. best 10.3
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Human immunodeficiency virus type 1 protease CHEMBL243 | Ki | 10.3 | 10.3 | 0.1 | 1 |
| MT4 CHEMBL388 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Human immunodeficiency virus type 1 protease | Ki | = | 0.05 | nM | 10.3 | Inhibition of HIV protease | 10866371 |
| MT4 | IC50 | = | 300.0 | nM | 6.52 | Compound was evaluated for its antiviral inhibition in MT-4 cell culture | 10866371 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 10866371 | 10.1016/s0960-894x(00)00163-3 | Human immunodeficiency virus type 1 protease | 1 |
| 10866371 | 10.1016/s0960-894x(00)00163-3 | MT4 | 1 |
Data from ChEMBL 36 via Core Engine